WOLVERINE ASSET MANAGEMENT LLC - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 31 filers reported holding NRX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,507
-50.2%
9,644
-7.3%
0.00%
Q2 2023$5,031
-31.5%
10,407
-6.6%
0.00%
Q1 2023$7,343
-58.2%
11,141
-29.6%
0.00%
Q4 2022$17,567
+3.3%
15,827
-34.8%
0.00%
Q3 2022$17,000
+6.2%
24,273
-13.4%
0.00%
Q2 2022$16,000
-81.0%
28,013
-18.5%
0.00%
-100.0%
Q1 2022$84,000
-52.5%
34,388
-7.3%
0.00%
-50.0%
Q4 2021$177,000
-55.1%
37,105
-12.8%
0.00%
-33.3%
Q3 2021$394,000
+74.3%
42,568
+118.4%
0.00%
+50.0%
Q2 2021$226,00019,4900.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 61,583$294,0000.03%
Alpine Global Management, LLC 25,326$121,0000.02%
Owl Creek Asset Management, L.P. 50,000$239,0000.02%
Engineers Gate Manager LP 25,210$121,0000.01%
Belvedere Trading LLC 26,900$89,0000.00%
Wealthcare Advisory Partners LLC 13,000$62,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 37,105$177,0000.00%
Belvedere Trading LLC 11,000$36,0000.00%
Psagot Value Holdings Ltd. / (Israel) 2,000$10,0000.00%
Quantbot Technologies LP 1,700$8,0000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders